InnoCan Pharma Corporation (CSE: INNO)
Canada
· Delayed Price · Currency is CAD 0.235
+0.025 (11.90%)
Nov 21, 2024, 11:31 AM EST
InnoCan Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 5.19 | 3.89 | 4.95 | 11.05 | 3.36 | 1.97 | Upgrade
|
| Cash & Short-Term Investments | 5.19 | 3.89 | 4.95 | 11.05 | 3.36 | 1.97 | Upgrade
|
| Cash Growth | 53.84% | -21.47% | -55.22% | 229.30% | 70.05% | 821.96% | Upgrade
|
| Accounts Receivable | 0.02 | 0.25 | 0.06 | - | 0 | - | Upgrade
|
| Other Receivables | 0.42 | 0.45 | 0.18 | 0.17 | 0.11 | 0.06 | Upgrade
|
| Receivables | 0.43 | 0.69 | 0.24 | 0.17 | 0.11 | 0.06 | Upgrade
|
| Inventory | 2.66 | 1.75 | 1.13 | 0.51 | 0.43 | - | Upgrade
|
| Prepaid Expenses | 0.21 | 0.34 | 0.45 | 0.72 | 0.31 | 0.43 | Upgrade
|
| Other Current Assets | 0.11 | 0.14 | 0.1 | 0.08 | 0.07 | 0.03 | Upgrade
|
| Total Current Assets | 8.59 | 6.8 | 6.88 | 12.52 | 4.28 | 2.49 | Upgrade
|
| Property, Plant & Equipment | 0.12 | 0.14 | 0.1 | 0.05 | 0.06 | 0.1 | Upgrade
|
| Total Assets | 8.72 | 6.94 | 6.98 | 12.58 | 4.33 | 2.58 | Upgrade
|
| Accounts Payable | 0.39 | 0.11 | 0.1 | 0.05 | 0.53 | 0.03 | Upgrade
|
| Accrued Expenses | - | 0.46 | 0.32 | 0.43 | 0.38 | 0.41 | Upgrade
|
| Current Portion of Leases | - | 0.02 | 0.01 | 0 | 0.04 | 0.03 | Upgrade
|
| Other Current Liabilities | 2.28 | 1.95 | 0.3 | 3.08 | 6.99 | 0.66 | Upgrade
|
| Total Current Liabilities | 2.67 | 2.54 | 0.73 | 3.56 | 7.94 | 1.13 | Upgrade
|
| Long-Term Leases | 0 | 0.01 | 0.02 | - | 0 | 0.04 | Upgrade
|
| Total Liabilities | 2.68 | 2.55 | 0.75 | 3.56 | 7.94 | 1.17 | Upgrade
|
| Additional Paid-In Capital | 39.33 | 37.18 | 34.77 | 33.67 | 10.96 | 6.02 | Upgrade
|
| Retained Earnings | -34.5 | -33.07 | -28.37 | -24.61 | -14.56 | -4.61 | Upgrade
|
| Total Common Equity | 4.83 | 4.1 | 6.39 | 9.06 | -3.61 | 1.41 | Upgrade
|
| Minority Interest | 1.22 | 0.28 | -0.17 | -0.04 | - | - | Upgrade
|
| Shareholders' Equity | 6.04 | 4.39 | 6.23 | 9.01 | -3.61 | 1.41 | Upgrade
|
| Total Liabilities & Equity | 8.72 | 6.94 | 6.98 | 12.58 | 4.33 | 2.58 | Upgrade
|
| Total Debt | 0 | 0.03 | 0.03 | 0 | 0.04 | 0.07 | Upgrade
|
| Net Cash (Debt) | 5.19 | 3.85 | 4.91 | 11.05 | 3.32 | 1.9 | Upgrade
|
| Net Cash Growth | 54.91% | -21.60% | -55.53% | 233.04% | 74.49% | 788.32% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.01 | 0.02 | 0.05 | 0.02 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 280.66 | 280.66 | 251.79 | 248.5 | 215.1 | 143.87 | Upgrade
|
| Total Common Shares Outstanding | 280.66 | 268 | 249.73 | 248.5 | 188.32 | 143.87 | Upgrade
|
| Working Capital | 5.92 | 4.26 | 6.15 | 8.96 | -3.66 | 1.36 | Upgrade
|
| Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.04 | -0.02 | 0.01 | Upgrade
|
| Tangible Book Value | 4.83 | 4.1 | 6.39 | 9.06 | -3.61 | 1.41 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | 0.02 | 0.03 | 0.04 | -0.02 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.